11/21/2025
Eli Lilly Becomes the First $1 Trillion Drugmaker as Weight-Loss Boom Reshapes Big Pharma
Eli Lilly has officially crossed the $1 trillion valuation mark, becoming the first pharmaceutical company in history to join a market-cap club previously dominated almost entirely by technology giants. The milestone reflects a dramatic reshaping of the healthcare landscape, driven by surging global demand for next-generation weight-loss and metabolic health treatments.
0
3 min read